Scientific & Technical Consulting

Scientific and technical consulting brings specialized judgment into development decisions that do not fit neatly inside one function. Programs stall on ambiguous assay results, conflicting literature, manufacturing process questions with clinical impact, or regulatory feedback that needs a scientific response rather than only a procedural one. In those moments, teams need someone who can read the data, name the decision, and write recommendations that hold up under scrutiny.

Viltis consultants step into those moments with clear problem framing, data review, and options the team can act on. Engagements may cover modality-specific science, analytical interpretation, CMC and clinical interfaces, or preparation for agency meetings where the science story must hold under questioning. We write and speak in plain technical language so R&D, clinical, quality, and leadership share one version of the problem. When vendors disagree or internal experts conflict, we help separate evidence from preference.

Engagements are scoped to a decision date whenever possible. We prefer short cycles with written options and a recommended path over open retainers that drift. When the science is genuinely unsettled, we say so and define the smallest experiment or analysis that would reduce the uncertainty enough to move. That keeps consulting spend tied to progress. Where needed, we bring in modality specialists under the same scoped decision frame so advice stays coordinated. Written recommendations stay attached to the decision record.

Consulting engagements commonly cover

• Technical issue assessment and root framing
• Data package review and gap identification
• Cross-functional scientific alignment sessions
• Support for agency meeting scientific Q&A
• Vendor and CRO scientific oversight
• Ad hoc expertise during program transitions
• Written recommendations for decision records

The value is a decision you can defend: what to study next, what to stop, and what to tell regulators or partners. Viltis stays accountable to that outcome rather than open-ended advisory theater. We document the rationale so the next team inheriting the program does not have to reverse-engineer why a choice was made six months earlier. If you need a rapid scientific read before a board, partner, or agency interaction, we can deliver a bounded assessment with clear options and a recommended path.